Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Name: Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
Published: 2011
License: Public Domain

AstraZeneca · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

copd pulmonary-disease

copd, copd exacerbation, lung diseases, respiratory disorders, pulmonary disease, chronic obstructive lung diseases, chronic obstructive airway disease, exacerbations, roflumilast, daliresp, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Related documents